摘要:
A composition comprising (A) 1,1,2,2,3-pentafluoropropane(CF2HCF2CFH2) and (B) at least one hydrofluorocarbon selected from the group consisting of 1,1,1,3,3-pentafluoropropane (CF3CH2CF2H) and 1,1,1,2,2,3,3,4,4-nonafluorobutane (CF3CF2CF2CF2H) is described. The composition is useful as a refrigerant and may be used in chillers as a replacement for refrigerant R-11.
摘要:
?PPA composition is described which comprises carbon dioxide (CO2), at least one hydrofluorocarbon selected from the group consisting of 1,1,1,2tetrafluoroethane (R-134a), 1,1,2,2-tetrafluoroethane (R-134) and 1,1difluoroethane (R-152a), and at least one hydrofluorocarbon selected from the group consisting of 1,1,1,3,3,3-hexafluoropropane (R-236fa) and 1,1,1,2,3,3-hexafluoropropane (R-236ea). The composition may additionally comprise at least one hydrocarbon and can be used as a replacement for refrigerant R-12 in automobile air conditioning and domestic refrigeration systems.
摘要:
A method for preparing a ternary or higher zeotropic refrigerant mixture comprising components of different volatilities is described. The method comprises: mixing together the less volatile components of the mixture in a pre-blending process; and separately adding the most volatile component to the pre-blended mixture by pressure or mass flow control so that the desired initial liquid composition is attained. The liquid zeotropic refrigerant mixture that is prepared may be transferred from a container in which it is held to another container or to a piece of equipment that is to use the refrigerant mixture. This method comprises the steps of: removing at least a portion of the prepared liquid zeotropic refrigerant mixture from a container in which it is held; charging the liquid zeotropic refrigerant mixture that is removed to another container or to a piece of equipment in which it is to be used; and adding at least the most volatile component of the refrigerant mixture to the holding container to compensate for the removal of liquid refrigerant mixture therefrom.
摘要:
A process for preparing a second compound stereo-selectively is described. The process comprises reacting a substrate comprising at least one first compound with a reagent in the presence of a biological catalyst and a solvent comprising at least one (hydro)fluorocarbon so as to convert a first compound into the second compound.
摘要:
A process for the purification of fluoromethyl hexafluoroisopropyl ether involving contacting a crude composition containing impure fluoromethyl hexafluoroisopropyl ether with an adsorbent having pores with a range of pore sizes whereby the difference between the smallest and largest pore size is at least 1 nm. The adsorbent suitably is a form of silica, alumina, or carbon.
摘要:
In the field of biomass extraction, there is a need for effective removal of solvent from spent biomass material. An apparatus for removing solvent residues includes a vessel (11) for containing biomass; a steam source (19) for supplying steam to contact the biomass; and a separator (24) for separating solvent from steam that has contacted the biomass. The disclosure also includes a method of use of the apparatus.
摘要:
A process for the purification of fluoromethyl hexafluoroisopropyl ether involving contacting a crude composition containing impure fluoromethyl hexafluoroisopropyl ether with an adsorbent having pores with a range of pore sizes whereby the difference between the smallest and largest pore size is at least 1 nm. The adsorbent suitably is a form of silica, alumina, or carbon.
摘要:
In a closed-loop biomass extraction apparatus (10), strategies for purifying HFC solvents used therein include: (i) contacting an adsorbent and a desiccant, e.g. in a container (26) with contaminated HFC solvent branched from the main flow loop; and, optionally, (ii) washing contaminated HFC solvent with water, e.g. in a vessel (34) to separate a co-solvent or entrainer, such as ethanol, thereform.
摘要:
Various embodiments of the present disclosure pertain to methods of optimizing a treatment efficacy of a biological system by tuning a property of the biological system through the addition of an optimizing agent to the biological system. The tuning can include: (a) determining a property parameter of the biological system; (b) selecting an optimizing agent to be added to the biological system based on the determined property parameter; and (c) adding the optimizing agent to the biological system. The optimizing agent can include a kosmotropic material. The biological system can include a tissue, such as a tumor. The methods of the present disclosure can be utilized to enhance the efficacy of various treatments, such as the heat treatment of a biological system exposed to a radiofrequency field. The methods of the present disclosure can also include a step of treating the biological system.
摘要:
A pharmaceutical solution for a medication delivery apparatus, especially a metered dose inhaler, is described. The pharmaceutical solution comprises: (a) a liquefied propellant component consisting essentially of and preferably consisting entirely of 1,1-difluoroethane (R-152a); (b) ethanol; and (c) a drug component dissolved in the propellant/ethanol mixture consisting of at least one drug selected from the group consisting of beclomethasone dipropionate (BDP) and fluticasone propionate (FP).